Drug Shortage Report for QUILLIVANT ER CHEWABLE TABLETS

Last updated on 2025-05-06 History
Report ID 256780
Drug Identification Number 02541602
Brand name QUILLIVANT ER CHEWABLE TABLETS
Common or Proper name METHYLPHENIDATE
Company Name KYE PHARMACEUTICALS INC.
Market Status MARKETED
Active Ingredient(s) METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 20MG
Dosage form(s) TABLET (CHEWABLE, EXTENDED-RELEASE)
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100 tablets
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2025-05-19
Actual start date
Estimated end date 2025-06-09
Actual end date
Shortage status Anticipated shortage
Updated date 2025-05-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2233 ARGENTIA ROAD, EAST TOWER, SUITE 302 & 302A
MISSISSAUGA, ONTARIO
CANADA L5N 2X7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2025-05-06 French Compare
v5 2025-05-06 English Compare
v4 2025-05-06 French Compare
v3 2025-05-06 English Compare
v2 2025-05-06 French Compare
v1 2025-05-06 English Compare

Showing 1 to 6 of 6